Algicid 500 mg+100 mg (Chewable Tablet)

Unit Price: ৳ 5.00 (10 x 10: ৳ 500.00)

Strip Price: ৳ 50.00

Medicine Details

Category	Details
Generic	Sodium alginate potassium bicarbonate
Company	Incepta pharmaceuticals ltd
Also available as	Algicid 500 mg suspension

Algicid is indicated for the treatment of symptoms resulting from the reflux of acid, bile and pepsin into the esophagus such as acid regurgitation, heartburn, indigestion
This is the combination of Sodium Alginate and Potassium Bicarbonate. Sodium Alginate is a naturally occurring substance. It reacts with the acid in the stomach to form a gel. Potassium Bicarbonate also reacts with the acid in the stomach to form bubbles of carbon dioxide.
A time interval of 2 hours should be considered between this intake and the administration of other medicinal products, especially tetracyclines, fluoroquinolones, iron salts, thyroid hormones, chloroquine, bisphosphonates, and estramustine.

Adults and children over 12 years: 1-2 tablets 3-4 times daily, after meals and before bedtime
Children 6-12 years: ½-1 tablet 3-4 times daily, after meals and before bedtime
Use in children: This is not recommended under 2 years of age
Elderly: No dose modifications are necessary for this age group
Hepatic Impairment: No dose modifications are necessary
Renal Insufficiency: Caution if a highly restricted salt diet is necessary

A time interval of 2 hours should be considered between this intake and the administration of other medicinal products, especially tetracyclines, fluoroquinolones, iron salts, thyroid hormones, chloroquine, bisphosphonates, and estramustine

Sodium alginate and potassium bicarbonate is contraindicated in patients with known hypersensitivity to these

Nausea
Constipation
Diarrhea
Headache
Sensation of swelling
In case too big dosage has been taken, there might appear a sensation of swelling

This combination (Sodium Alginate and Potassium Bicarbonate) can be used during pregnancy, if clinically needed
No known effect on breast-fed infants
This combination can be used during breastfeeding

Sodium Alginate and Potassium Bicarbonate should be prescribed with caution in patients with renal impairment and congestive cardiac failure
Care needs to be taken in treating patients with hypercalcemia, nephrocalcinosis and recurrent calcium-containing renal calculi
There is a possibility of reduced efficacy in patients with very low levels of gastric acid
If symptoms do not improve after seven days, the clinical situation should be reviewed